CELYAD ONCOLOGY SA Adjustments For Amortisation Expense
CELYAD ONCOLOGY SA reported Adjustments For Amortisation Expense of EUR 253.00 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForAmortisationExpense · last filed 2023-09-05
| Period end | Adjustments For Amortisation Expense 6 month | Adjustments For Amortisation Expense 12 month |
|---|---|---|
| 2023-06-30 | 253.00K EUR 6-K · filed 2023-09-05 | |
| 2022-12-31 | 613.00K EUR 20-F · filed 2023-03-23 | |
| 2022-06-30 | 455.00K EUR 6-K · filed 2023-09-05 | |
| 2021-12-31 | 217.00K EUR 20-F · filed 2023-03-23 | |
| 2021-06-30 | 106.00K EUR 6-K · filed 2022-08-05 | |
| 2020-12-31 | 197.00K EUR 20-F · filed 2023-03-23 | |
| 2020-06-30 | 95.00K EUR 6-K · filed 2021-08-04 | |
| 2019-12-31 | 169.00K EUR 20-F · filed 2022-03-24 | |
| 2019-06-30 | 81.00K EUR 6-K · filed 2020-08-07 | |
| 2018-12-31 | 66.00K EUR 20-F · filed 2021-03-24 | |
| 2018-06-30 | 33.00K EUR 6-K/A · filed 2019-09-05 | |
| 2017-12-31 | 8.04M EUR 20-F · filed 2020-03-25 | |
| 2016-12-31 | 756.00K EUR 20-F · filed 2019-04-05 | |
| 2015-12-31 | 760.00K EUR 20-F · filed 2018-04-06 |